Gandalusao, Nestor D.

HRN: 28-56-47  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/14/2026
CO-AMOXICLAV 625MG (TAB)
02/14/2026
02/21/2026
PO
625mg
BID
Lacerated Wound
Pending Pharmacy Acceptance 

 Indication:  Prophylaxis    Type of Infection:  Skin & Soft Tissue    Compliance to guidelines: